Ex vivo effects of ticlopidine on human platelets: inhibition of fibrinogen binding by a mechanism independent of thromboxane formation
Iovine, C.; d'Avenia, V.; Turco, S.; Mattioli, P.L.; di Minno, G.
Agents and Actions. Supplements 15: 105-107
1984
ISSN/ISBN: 0379-0363 PMID: 6592941 Document Number: 223432
Document emailed within 1 workday
Related Documents
Harfenist, E.J.; Packham, M.A.; Kinlough-Rathbone, R.L.; Mustard, J.F. 1981: Inhibitors of ADP-induced platelet aggregation prevent fibrinogen binding to rabbit platelets and cause rapid deaggregation and dissociation of bound fibrinogen Journal of Laboratory and Clinical Medicine 97(5): 680-688Lin, Y.; Waer, M. 1996: In vivo mechanism of action of leflunomide: selective inhibition of the capacity of B lymphocytes to make T-independent xenoantibodies Transplantation Proceedings 28(6): 3085
Golino, P.; Ambrosio, G.; Gresele, P.; Pascucci, I.; Ragni, M.; Russolillo, E.; Leproux, G.B.; Chiariello, M. 1993: The in vivo antiplatelet effects of thromboxane A2 synthase inhibitors are potentiated by simultaneous thromboxane A2/prostaglandin H2 receptor blockade Journal of Pharmacology and Experimental Therapeutics 266(2): 511-517
Basevich, V.V.; Mevkh, A.T.; Varfolomeev, S.D. 1984: Kinetic mechanisms of enzyme activity of the thromboxane synthetase system. Thromboxane synthetase of human platelets Biokhimiia 49(9): 1538-1545
Wlodar, S.J.; Stone, D.L.; Sinor, L.T. 1995: Trimeresurus venom inhibition of anti-HPA-1a and anti-HPA-1b antibody binding to human platelets Immunohematology 11(4): 129-132
Faraday, N.; Goldschmidt-Clermont, P.; Dise, K.; Bray, P.F. 1994: Quantitation of soluble fibrinogen binding to platelets by fluorescence-activated flow cytometry Journal of Laboratory and Clinical Medicine 123(5): 728-740
Bruno, J.J.; Chang, L.F.; McSpadden, M.M.; Yang, D. 1984: The effect of oral ticlopidine on arachidonic acid products in human platelets Agents and Actions. Supplements 15: 76-87
Ditter, H.; Matthias, F.R.; Lasch, H.G. 1984: Comparison of sympathomimetic amines with collagen, calcium ionophor and adenosine diphosphate in their effects on thromboxane formation of human platelet rich plasma Folia Haematologica 111(6): 761-768
Chevolet, C.; Grosdent, J.C.; Reiters, G.M.; Dresse, A. 1982: Platelet aggregation measured in rabbit whole blood: in vitro study of 3 aggregating agents and ex vivo inhibition by aspirin and ticlopidine Archives Internationales de Pharmacodynamie et de Therapie 259(2): 310-311
Ko, F.N.; Wu, T.S.; Liou, M.J.; Huang, T.F.; Teng, C.M. 1989: Inhibition of platelet thromboxane formation and phosphoinositides breakdown by osthole from Angelica pubescens Thrombosis and Haemostasis 62(3): 996-999
Henricsson, A.; Husberg, B.; Bergentz, S.E. 1977: The mechanism behind the effect of ALG on platelets in vivo Clinical and Experimental Immunology 29(3): 515-522
Kubisz, P.; Suranová, J. 1973: Aggregation of human platelets after induction by bovine fibrinogen Casopis Lekaru Ceskych 112(36): 1103-1108
Scotto di Tella, A.M.; Levy, C.; Lacarelle, B.; Tissot, R. 1986: Binding of tritiated imipramine to human platelets. 1 or several binding sites? L'Encephale 12(1): 13-17
Pizzoferrato, A.; D'Addato, M.; Cenni, E.; Curti, T.; Cavedagna, D.; Tarabusi, C.; Cifiello, B. 1983: Synthesis of thromboxane B2 and prostaglandin F2 alpha by human platelets after contact with biomaterials used in vascular surgery Life Support Systems: the Journal of the European Society for Artificial Organs 1(Suppl 1): 251-254
Misselwitz, F.; Hofmann, U.; Leytin, V.L.; Repin, V.S. 1987: Influence of thromboxane receptor-antagonists on the interaction of platelets with solid-phase immobilized human collagen Biomedica Biochimica Acta 46(7): 595-598
Forsberg, P.O. 1989: Dephosphorylation of human fibrinogen, previously phosphorylated in vitro by protein kinase C, by whole blood or intestinal alkaline phosphatase. Effects on thrombin-induced gelation of in vitro dephosphorylated human fibrinogen Thrombosis Research 53(1): 1-9
Morgenstern, E.; Edelmann, L.; Reimers, H.J.; Miyashita, C.; Haurand, M. 1985: Fibrinogen distribution on surfaces and in organelles of ADP stimulated human blood platelets European Journal of Cell Biology 38(2): 292-300
Thomas, M.; Massimi, P.; Jenkins, J.; Banks, L. 1995: HPV-18 E6 mediated inhibition of p53 DNA binding activity is independent of E6 induced degradation Oncogene 10(2): 261-268
Legrand, C.; Nurden, A.T. 1985: Studies on platelets of patients with inherited platelet disorders suggest that collagen-induced fibrinogen binding to membrane receptors requires secreted ADP but not released alpha-granule proteins Thrombosis and Haemostasis 54(3): 603-606
Wielosz, M.; Przegalinski, E.; Kleinrok, Z. 1979: In vivo effect of danitracen on the uptake mechanism in monoaminergic neurons and platelets in rats Agressologie: Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de l'Agression 20(D): 253-257